Additional ISC Approved Research Projects
Descriptive Study of the Incidence of Malignancy in Severe Asthma Patients Receiving Benralizumab and Other Therapies: a Post Authorization Safety Study (PASS)
- To assess the incidence of malignancies in severe asthma patients receiving benralizumab compared with those receiving non-benralizumab biologics, and those not receiving biologics.
- To describe the clinical characteristics of the new malignancy cases that develop in severe asthma patients and relevant subgroups.
Dr Laura Liu